SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 819.94 |
| Enterprise Value ($M) | 800.54 |
| Book Value ($M) | 55.56 |
| Book Value / Share | 0.17 |
| Price / Book | 14.76 |
| NCAV ($M) | 7.07 |
| NCAV / Share | 0.02 |
| Price / NCAV | 115.95 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.19 |
| Return on Assets (ROA) | -0.15 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.54 |
| Current Ratio | 1.70 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 230.37 |
| Assets | 278.86 |
| Liabilities | 223.30 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 99.38 |
| Operating Income | 18.07 |
| Net Income | -28.01 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -10.23 |
| Cash from Investing | -8.13 |
| Cash from Financing | 94.01 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Barnard Robert James | 3.40 | ||
| 13G | Ca Pipe Spv, Llc | 8.75 | ||
| 13D/A | Kingsley Kyle Eugene | 6.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| VGLS – VG Life Sciences Inc. | VICP – Vicapsys Life Sciences, Inc. |
| VIRX – Viracta Therapeutics, Inc. | WCUI – Wellness Center USA, Inc. |
| XSNX – NovAccess Global Inc. |
Financial data and stock pages provided by
Fintel.io